Aortic valve replacement for aortic stenosis in the elderly and in those with impaired left ventricular function (selected series)
| Series | n | 30 day operative mortality | Event free survival | ||||
|---|---|---|---|---|---|---|---|
| Culliford 1991 | Age ⩾ 80 years | AVR | 35 | 5.7% | 93.3% at 1 year | ||
| AVR+CABG | 36 | 19.4% | 80.4% at 3 years | ||||
| Azariades 1991 | Age ⩾ 80 years | AVR±CABG | 88 | 16% | 5 years 64 (7)% | ||
| Olsson1992 | Age ⩾ 80 years | AVR±CABG | 44 | 14% | 2 years 73% | ||
| Age 65–75years | AVR±CABG | 83 | 4% | 2 years 90% | |||
| Elayda1993 | Age ⩾ 80 years | AVR | 77 | 5.2% | 1 year 90.8% | ||
| AVR+CABG | 75 | 24% | 5 years 76% | ||||
| Logeais1994 | Age ⩾ 75 years | AVR±CABG | 675 | 12.4% | |||
| Connolly 1997 | EF ⩽ 35% | AVR±CABG | 154 | 9% | EF improved in 76% | ||
AVR, aortic valve replacement; CABG, coronary artery bypass graft; MI, myocardial infarction; EF, ejection fraction.
Sources: Culliford AT, et al. Am J Cardiol1991;67:1256–60; Azariades M,et al. Eur J Cardiothorac Surg 1991;5:373–7; Olsson M, et al. J Am Coll Cardiol 1992;20:1512-16; Elayda MA, et al. Circulation1993;88:II-1–6; Logeais Y,et al. Circulation1994;90:2891–8; Connolly HM. Circulation1997;95:2395–400.